Amoroso Michael

Amoroso Michael is listed in filings as President and CEO at Precision BioSciences, Inc.. This profile follows SEC Form 4 activity through Feb 19, 2026, including sale activity. Recent filings connect the profile to Precision BioSciences, Inc. (DTIL) and Abeona Therapeutics Inc. (ABEO). The current snapshot covers public activity from Jul 9, 2024 to Feb 19, 2026. Reported amounts are shown as $78.9K to $22.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.